Workflow
Biotech and Pharma
icon
Search documents
NanoViricides says antiviral NV-387 may reduce cancer resurgence risk tied to viral infections
Proactiveinvestors NA· 2025-08-18 13:35
Company Overview - Proactive is a publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team operates from key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - The company specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive delivers news and insights across various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for being a forward-looking and enthusiastic adopter of technology, utilizing decades of expertise and experience among its content creators [4] - The company employs automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Candel Therapeutics advances toward prostate cancer therapy filing after trial success
Proactiveinvestors NA· 2025-08-14 12:51
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Lisata Therapeutics advances lead cancer drug, expects key trial results by year-end
Proactiveinvestors NA· 2025-08-07 20:27
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]
Hims & Hers shares fall on mixed Q2 report, light revenue forecast
Proactiveinvestors NA· 2025-08-05 13:37
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced and qualified news journalists who produce independent content [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The news team delivers insights across various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Sona Nanotech launches first human trial for groundbreaking cancer therapy
Proactiveinvestors NA· 2025-08-01 12:58
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]
Zynex eyes growth revival under new CEO, advances oximeter technology
Proactiveinvestors NA· 2025-07-31 20:26
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
Globenewswire· 2025-07-31 20:05
Core Viewpoint - 4D Molecular Therapeutics announced positive results from the SPECTRA clinical trial for 4D-150 in diabetic macular edema (DME), indicating a potential shift in treatment paradigms and alignment with the European Medicines Agency (EMA) for a registrational pathway [1][6]. Clinical Trial Results - The SPECTRA trial demonstrated that 4D-150 is well tolerated with no intraocular inflammation observed at any timepoint or dose level [4] - The Phase 3 dose of 4D-150 achieved a clinically meaningful 78% reduction in treatment burden compared to the standard-of-care aflibercept 2mg every eight weeks [4][10] - Efficacy results showed a sustained gain in best corrected visual acuity (BCVA) of +9.7 letters and a reduction in central subfield thickness (CST) of -174 µm [5] Regulatory Alignment - Both the FDA and EMA have aligned on a single Phase 3 clinical trial as acceptable for regulatory submission for 4D-150 in DME, streamlining the path for marketing authorization [6][9] Product Overview - 4D-150 is designed to provide multi-year sustained delivery of anti-VEGF from a single intravitreal injection, aiming to reduce the treatment burden associated with current therapies [7][9] - The investigational agent targets both wet age-related macular degeneration and DME, addressing significant unmet medical needs in these conditions [7][11] Market Context - DME is a prevalent complication of diabetic retinopathy, affecting approximately one million individuals in the U.S., characterized by inflammation and swelling in the macula leading to vision loss [8]
Honeywell raises full-year outlook after Q2 beat
Proactiveinvestors NA· 2025-07-24 13:59
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Thermo Fisher shares surge after Q2 beat, boosted by product launches
Proactiveinvestors NA· 2025-07-23 15:36
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced and qualified news journalists who produce independent content [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Sona Nanotech gets ethics board nod for pilot melanoma cancer trial in Canada
Proactiveinvestors NA· 2025-07-23 12:54
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...